NCT05252390 2025-11-06NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid TumorsNuvation Bio Inc.Phase 1 Terminated82 enrolled
NCT05169684 2025-06-10A Study of BMS-986218 or BMS-986218 Plus Nivolumab in Combination With Docetaxel in Participants With Metastatic Castration-resistant Prostate CancerBristol-Myers SquibbPhase 2 Terminated10 enrolled 15 charts